Fatigue, depression and chronic hepatitis C infection

Related Experiment Video

Updated: Oct 2, 2026

A Standardized Copper Bian-Stone Gua Sha Protocol for Treating Chronic Fatigue Syndrome in Human Subjects
06:43

A Standardized Copper Bian-Stone Gua Sha Protocol for Treating Chronic Fatigue Syndrome in Human Subjects

Published on: July 3, 2026

Simon Wessely1, Carmine Pariante

  • 1Department of Psychological Medicine, Guy's King's and St Thomas' School of Medicine and Institute of Psychiatry, London.

Psychological Medicine
|March 9, 2002
PubMed

Insights

Hepatitis C virus (HCV) infection is not directly linked to depression or fatigue. Existing associations are often due to other factors like awareness of diagnosis or advanced liver disease, not the virus itself.

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Psychiatry

Background:

  • Hepatitis C virus (HCV) infection is a significant global health concern.
  • The potential link between uncomplicated HCV infection and psychological symptoms like depression and fatigue requires investigation.

Purpose of the Study:

  • To determine if a correlation exists between uncomplicated Hepatitis C virus (HCV) infection and the presence of depression or fatigue.
  • To differentiate between HCV-specific effects and confounding factors influencing these symptoms.

Main Methods:

  • A comprehensive review of existing medical literature was conducted.
  • Studies examining the association between HCV status and depression/fatigue were analyzed.

Main Results:

  • An association between HCV infection and depression or fatigue was observed in specific subgroups, including those aware of their positive status, individuals with advanced liver disease, and patients at specialist centers.
  • However, these findings are subject to significant biases.
  • Studies with independent assessments of HCV status and symptoms did not suggest an association, and conventional markers of liver disease showed no correlation with depression or fatigue.

Conclusions:

  • Current evidence does not support a direct association between Hepatitis C virus (HCV) infection itself and fatigue or depression.
  • Risk factors for fatigue in other illnesses, such as metabolic and mood disorders, demographics, and exercise levels, are also relevant to HCV patients.
  • While theoretical mechanisms exist, compelling epidemiological data for an HCV-specific fatigue or depression factor is lacking.
Abstract

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Chronic Pancreatitis II: Pathophysiology01:21

Chronic Pancreatitis II: Pathophysiology

Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...